Dosing Done Right: The PCDI Survey & Why It Matters
MBC Patients, Diagnosis and Treatment, Medical Community, Clinical Research, Patient Advocates, Patient Initiatives Our MBClife MBC Patients, Diagnosis and Treatment, Medical Community, Clinical Research, Patient Advocates, Patient Initiatives Our MBClife

Dosing Done Right: The PCDI Survey & Why It Matters

This episode of Our MBC Life features Stephanie Walker and Julia Maués of the Patient-Centered Dosing Initiative team who have been working on the 2025 reboot of its groundbreaking 2020 patient survey. Julia and Stephanie break down how treatment doses are typically determined during clinical trials and why individualized dosing, based on more than your diagnosis, is so important for people living with metastatic breast cancer. They also chat about the newly launched 2025 Patient Dosing Survey that you can take right now, where to find it and why your experience about metastatic breast cancer treatment matters.

Read More
PI(3)King the Right Target
MBC Patients, Living with MBC, Making Our Best MBC Life, Biomarker Testing, Patient Initiatives Our MBClife MBC Patients, Living with MBC, Making Our Best MBC Life, Biomarker Testing, Patient Initiatives Our MBClife

PI(3)King the Right Target

PI(3)King the right target after CDK4/6 inhibitors fail patients is an exciting area of research and FDA approval. Now that there are multiple options approved by the FDA and more to come, patients have more treatment choices. Join host Abigail Johnston as she interviews 2 patients who give us their perspective on these advances, as well as a doctor whose scientific research has led the way identifying PIK3CA mutations as a cancer genomic biomarker.

Read More